Susquehanna International Group’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $389K | Buy |
46,851
+16,593
| +55% | +$138K | ﹤0.01% | 4677 |
|
2025
Q1 | $184K | Buy |
30,258
+17,826
| +143% | +$109K | ﹤0.01% | 5564 |
|
2024
Q4 | $78.6K | Buy |
+12,432
| New | +$78.6K | ﹤0.01% | 5752 |
|
2024
Q2 | – | Sell |
-22,599
| Closed | -$251K | – | 5910 |
|
2024
Q1 | $251K | Buy |
22,599
+7,559
| +50% | +$84.1K | ﹤0.01% | 4415 |
|
2023
Q4 | $169K | Buy |
+15,040
| New | +$169K | ﹤0.01% | 5096 |
|
2023
Q3 | – | Sell |
-11,429
| Closed | -$101K | – | 5802 |
|
2023
Q2 | $101K | Sell |
11,429
-149,891
| -93% | -$1.32M | ﹤0.01% | 4998 |
|
2023
Q1 | $1.34M | Buy |
161,320
+53,707
| +50% | +$447K | ﹤0.01% | 2484 |
|
2022
Q4 | $1.03M | Buy |
+107,613
| New | +$1.03M | ﹤0.01% | 2296 |
|
2022
Q3 | – | Sell |
-49,075
| Closed | -$277K | – | 6359 |
|
2022
Q2 | $277K | Sell |
49,075
-84,889
| -63% | -$479K | ﹤0.01% | 4099 |
|
2022
Q1 | $750K | Sell |
133,964
-137
| -0.1% | -$767 | ﹤0.01% | 3175 |
|
2021
Q4 | $590K | Buy |
134,101
+107,159
| +398% | +$471K | ﹤0.01% | 3571 |
|
2021
Q3 | $254K | Buy |
26,942
+12,544
| +87% | +$118K | ﹤0.01% | 4463 |
|
2021
Q2 | $105K | Buy |
+14,398
| New | +$105K | ﹤0.01% | 5052 |
|
2021
Q1 | – | Sell |
-11,368
| Closed | -$85K | – | 5344 |
|
2020
Q4 | $85K | Sell |
11,368
-21,492
| -65% | -$161K | ﹤0.01% | 4531 |
|
2020
Q3 | $199K | Sell |
32,860
-126,088
| -79% | -$764K | ﹤0.01% | 3891 |
|
2020
Q2 | $1.33M | Buy |
158,948
+70,430
| +80% | +$588K | ﹤0.01% | 1842 |
|
2020
Q1 | $526K | Buy |
88,518
+31,742
| +56% | +$189K | ﹤0.01% | 2825 |
|
2019
Q4 | $368K | Buy |
56,776
+34,736
| +158% | +$225K | ﹤0.01% | 2962 |
|
2019
Q3 | $106K | Buy |
+22,040
| New | +$106K | ﹤0.01% | 4069 |
|
2018
Q2 | – | Sell |
-56,707
| Closed | -$686K | – | 3953 |
|
2018
Q1 | $686K | Buy |
+56,707
| New | +$686K | ﹤0.01% | 1813 |
|